American Dental Laser, Inc.
This article was originally published in The Gray Sheet
Executive SummarySigns a letter of intent granting Minneapolis-based Patterson Dental Company exclusive marketing rights to ADL's KCP 2000 dental treatment device, which FDA cleared for marketing in December 1992. The KCP 2000 "sprays away tooth structure and decay using minute particles of alpha alumina," according to ADL. The firm is positioning the device as an alternative to the drill, saying that "it eliminates a number of time-consuming steps in the placement of tooth-colored fillings and often allows the dentist to treat decay at an earlier stage." Patterson employs 500 direct sales representatives and "equipment specialists" around the country.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.